Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (further cardiovascular outcomes research with PCSK9 Inhibition in subjects with elevated risk) - Bonaca, M P; Nault, P; Giugliano, R P (Circulation, 2018)
, et al.